Skip to main content
. 2024 Jun 7;28(2):362. doi: 10.3892/ol.2024.14495

Figure 2.

Figure 2.

Kaplan-Meier estimates and corresponding 95% confidence intervals of clinical outcomes for (A) patients with LPC vs. LAPC and (B) patients with high-risk vs. non-high-risk LPC. LPC, localised prostate cancer; LAPC, locally advanced prostate cancer; PSA, prostate-specific antigen.